Document Detail


Immunity, thyroid function and pregnancy: molecular mechanisms.
MedLine Citation:
PMID:  20421883     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pregnancy and the postpartum period have a profound effect on autoimmune thyroid disease. Graves disease ameliorates during pregnancy, only to relapse postpartum, whereas postpartum thyroiditis is caused by destructive thyroiditis during the first few months after delivery. The immunology of pregnancy underlies these changes: the mother must maintain tolerance of the fetal semi-allograft while not suppressing her own immune system and exposing herself and the fetus to infection. Nonspecific factors, including hormonal changes, trophoblast expression of key immunomodulatory molecules and a switch to a predominantly T-helper-2-type pattern of cytokines, play some part in the maintenance of transient tolerance to paternal antigens in pregnancy; however, the generation of specific regulatory T (T(REG)) cells is key to this maintenance. T(REG) cells preferentially accumulate in the decidua but may also be present in the mother's circulation and are thus capable of regulating coincidental autoimmune responses through the phenomenon of linked suppression. In turn, this suppression may explain why thyroid autoantibody levels decline during pregnancy, which leads to remission of Graves disease. Postpartum exacerbation of autoimmunity may reflect an imbalance in T(REG) cells, which is caused by the rapid fall in the numbers of these cells after delivery.
Authors:
Anthony P Weetman
Related Documents :
19844123 - Perinatal goiter with increased iodine uptake and hypothyroidism due to excess maternal...
10616163 - Decreased parotid saliva gustin/carbonic anhydrase vi secretion: an enzyme disorder man...
17077233 - Patient refusal of emergency cesarean delivery: a study of obstetricians' attitudes in ...
Publication Detail:
Type:  Journal Article; Review     Date:  2010-04-27
Journal Detail:
Title:  Nature reviews. Endocrinology     Volume:  6     ISSN:  1759-5037     ISO Abbreviation:  Nat Rev Endocrinol     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-26     Completed Date:  2010-09-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101500078     Medline TA:  Nat Rev Endocrinol     Country:  England    
Other Details:
Languages:  eng     Pagination:  311-8     Citation Subset:  IM    
Affiliation:
Department of Human Metabolism, Faculty of Medicine, Dentistry and Health, University of Sheffield, The Medical School, Beech Hill Road, Sheffield S10 2RX, UK. a.p.weetman@sheffield.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Autoantibodies / blood
Autoimmune Diseases / metabolism,  physiopathology*
Autoimmunity*
Cytokines / metabolism
Female
Histocompatibility Antigens / blood
Humans
Immune Tolerance
Placenta / immunology
Postpartum Period
Pregnancy / immunology*
Puerperal Disorders / metabolism,  physiopathology*
T-Lymphocytes, Regulatory / metabolism
Thyroid Diseases / metabolism,  physiopathology*
Thyroid Gland / physiopathology*
Chemical
Reg. No./Substance:
0/Autoantibodies; 0/Cytokines; 0/Histocompatibility Antigens

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diagnosis and treatment of apolipoprotein B dyslipoproteinemias.
Next Document:  Nuclear hormone receptors in diabetic nephropathy.